Article Text

Download PDFPDF
CASE REPORT
Immeasurable glycosylated haemoglobin: a marker for severe haemolysis
  1. Nidhi Aggarwal1,
  2. Anand Kumar Rai2,
  3. Yizhak Kupfer1,
  4. Sidney Tessler2
  1. 1Division of Pulmonary & Critical Care Medicine, Department of Medicine, Maimonides Medical Center, Brooklyn, New York, USA
  2. 2Department of Medicine, Maimonides Medical Center, Brooklyn, New York, USA
  1. Correspondence to Dr Sidney Tessler, stessler{at}maimonidesmed.org, ishargel{at}maimonidesmed.org

Summary

Glycosylated haemoglobin (HbA1c) is a measurement commonly performed in patients with diabetes. Factors causing a change in the life span of the red blood cell (RBC) can affect the measurement of HbA1c. Thus haemolysis is an important factor that may affect the HbA1c level determination. Haemolysis has been shown to cause a falsely low HbA1c. A 62-year-old man with a history of autoimmune haemolytic anaemia was admitted for severe haemolytic anaemia and an Hb of 2.9 g/dL. HbA1c tested during hospitalisation was unrecordable due to the extremely low Hb. The patient was treated with intravenous steroids, immunoglobulin, fluids and RBC transfusions but continued to haemolyse and eventually expired. We emphasise that an extremely low HbA1c level can serve as a marker of haemolysis and an unrecordable HbA1c level may point towards fatal haemolysis.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.